Fintel reports that on March 21, 2025, Goldman Sachs downgraded their outlook for Charles River Laboratories International (BMV:CRL) from Buy to Neutral. Wellington Management Group Llp holds 4 ...
Goldman Sachs downgraded contract research organizations Icon Public Limited (NASDAQ:ICLR) and Charles River Laboratories (NYSE:CRL) to Neutral from Buy on Friday, citing a challenging near-term ...